- ►diabetesjournals.org JM Lawrence, J Reid, GJ Taylor, C Stirling, JPD … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Sixty overweight type 2 diabetic patients not on
lipid-lowering therapy were randomized to metformin, pioglitazone, or gliclazide after a 3-month
dietary run-in. Drug doses were uptitrated for 3 months to optimize glycemia and were ... Cited by 49 - Related articles - BL Direct - All 8 versions
S Nagasaka, Y Aiso, K Yoshizawa, S … - Diabetic medicine, 2004 - interscience.wiley.com Methods Seventy-eight Japanese subjects with Type 2 diabetes mellitus poorly controlled with
sulphonylureas [38 men and 40 women, aged 57 ± 9 years, body mass index 25.2 ± 1.4 kg/m
2 , and HbA 1c 8.3 ± 0.6% (means ± sd)] were randomly assigned to groups for the ... Cited by 27 - Related articles - BL Direct - All 4 versions
DJ Betteridge, B Verges - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: The aim of this study was to determine the long-term effects of pioglitazone
add-on to metformin or sulphonylurea on plasma lipids and lipo- proteins. Materials and
methods: The effects of piogli- tazone were studied in two clinical trials in patients with ... Cited by 37 - Related articles - BL Direct - All 3 versions
- ►sherbornegibbs.com [PDF] A Perez, M Khan, T Johnson, M … - Diabetes & Vascular …, 2004 - dvr.sagepub.com Abstract Objective T o determine the effect of pioglitazone plus metformin or a sulphonylurea
on lipoprotein particle size and subclass distribution in patients with type 2 diabetes. Methods
Lipid profiles were determined for blood samples from patients participating in two ... Cited by 22 - Related articles - All 7 versions
T Hirano, G Yoshino, T Kazumi - Annals of internal medicine, 1998 - Am Coll Physicians The Editors welcome submissions for possible publication in the Letters section. Authors of letters
should: • Include no more than 300 words of text, three authors, and five references • Type with
double-spacing • Send three copies of the letter, an authors' form (see Table of Contents ... Cited by 23 - Related articles - BL Direct - All 3 versions
M Hanefeld, P Brunetti, GH Schernthaner, DR … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c was reduced by 1.20% in the SU plus pioglitazone group and 1.36% in the
SU plus metformin group, and fasting plasma glucose was reduced by 2.2 and 2.3 mmol/l in
the respective groups. Fasting insulin levels were also reduced (pioglitazone arm −1.3 ... Cited by 98 - Related articles - BL Direct - All 5 versions
V Mattoo, D Eckland, M Widel, S Duran, C Fajardo, J … - Clinical therapeutics, 2005 - Elsevier This was a 6-month, randomized, double-blind, prospective, multicenter, placebo-controlled,
parallel-group study. Patients with type 2 DM and a glycosylated hemoglobin (HbA 1c ) value
≥7.5% who were using insulin (with or without OAMs) entered a 3-month insulin ... Cited by 40 - Related articles - All 4 versions
MH Tan, D Johns, J Strand, J Halse, S … - Diabetic …, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 38 - Related articles - BL Direct - All 6 versions
Z Kerenyi, H Samer, R James, Y Yan, M Stewart - Diabetes research and clinical …, 2004 - Elsevier Aim: To compare the efficacy of combination therapy using rosiglitazone (8 mg per day) and
glibenclamide (7.5 mg per day) with upward titration of glibenclamide as monotherapy (maximum
dose=15 mg per day) in reducing HbA 1c levels over 26 weeks in patients with type 2 ... Cited by 50 - Related articles - All 8 versions
G Derosa, AV Gaddi, L Ciccarelli, E Fogari, … - The Journal of …, 2005 - ingentaconnect.com We evaluated the effect of glimepiride plus metformin and rosiglitazone plus metformin on
glucose, and on cardiovascular risk parameters such as lipoprotein(a) (Lp[a]) and homocysteine
(HCT) in patients with type 2 diabetes and metabolic syndrome. Ninety-nine patients in ... Cited by 15 - Related articles - All 7 versions
